Halothane selectively inhibits bradykinin-induced synovial plasma extravasation

Area of Science:

• Anesthesiology
• Pharmacology
• Immunology

Background:

• In vitro studies suggest halothane, unlike isoflurane, inhibits bradykinin-induced endothelial cell responses.
• Bradykinin is a key mediator in inflammatory processes.

Purpose of the Study:

• To investigate the in vivo effects of halothane, isoflurane, and pentobarbital on bradykinin-induced plasma extravasation in rats.
• To compare the anti-inflammatory properties of different anesthetics on a key component of tissue inflammation.

Main Methods:

• Rats were anesthetized with halothane (0.8 or 1.3 minimum alveolar concentration [MAC]), isoflurane (1.3 MAC), or pentobarbital.
• Plasma extravasation was induced by intra-articular administration of bradykinin or platelet-activating factor and quantified by measuring Evans blue dye in perfusate.

Main Results:

• Bradykinin significantly increased plasma extravasation in rats anesthetized with pentobarbital or isoflurane.
• Halothane markedly reduced bradykinin-induced plasma extravasation in a dose-dependent manner (40% at 0.8 MAC, 15% at 1.3 MAC).
• Baseline plasma extravasation was lower with halothane compared to pentobarbital or isoflurane; platelet-activating factor-induced extravasation was similar across all anesthetics.

Conclusions:

• Halothane, but not isoflurane or pentobarbital, inhibits both baseline and bradykinin-induced plasma extravasation.
• Volatile anesthetics demonstrate differential modulation of inflammatory responses.
• These findings highlight halothane's potential anti-inflammatory effects in vivo.